Créatine monohydrate
Food supplement declared in France, declaration No 2024-6-1032
Créatine monohydrate (Revogenix) is a food supplement declared in France. Status: retrait du marché annoncé pour le 10 March 2027. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- Revogenix
- Food business operator placing the product on the market
- LABORATOIRE TERRAVITA
- Status
- Retrait du marché annoncé pour le 10 March 2027
- Form
- Poudre
- Daily dose
- 3g de poudre
- Objectives stated by the manufacturer (these are not authorised claims)
- Sport
Declaration 142891, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Information
Retrait du marché annoncé pour le 10 March 2027, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Monohydrate de créatine | not declared |
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Femmes enceintes ou allaitantes, prenez conseil auprès d'un professionnel de la santé avant utilisation
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
This name is used by more than 10 declarations from different companies, so it does not identify one product. See every declaration with this name.
Brand : Revogenix